In terms of governance three main levels are described as per the organogram: The strategic, the coordination and the operational levels.
Within the Strategic Level, all members of the Consortium will be represented in the General Assembly and they all will meet at the end of each project year. During the Assembly the designated candidate from the Steering Committee, the Scientific Advisory Committee and the Coordinator, will give an updated on the status of the Consortium as well as the milestones achieved and deliverables produced. The General Assembly will be the annual forum to share: activities and present results, as well as ongoing activities, disease hot topics and future implementation plans. Major decisions taken by the Steering Committee will be presented to the Assembly in order to ensure transparency. No major decisions will be taken during the General Assembly, this will correspond to the Steering Committee, composed of all PIs from full members, work package and node leaders. TESA network will have a Scientific Advisory Committee (SAC) who will assess the adequacy of programs, resources and capabilities and advise on the strategy of transferring research results (among others). The SAC shall be comprised of 3 members , selected on the basis of individual scientific or technical competence. Members serve for a period of 3 years and may be reappointed.
SAC Members are: Dr. Casamitjana (Spain), Dr.Muquingue (Mozambique) and Dr.Hakim (Zimbabwe).

Within the Coordination Level, there will be a Coordination Committee, who will include all work package leaders, node leaders (node leader = disease specific leaders) and the Coordinator will be part of this Committee. Work Package (WP) Leaders: play a very important role in the project as they have a much greater understanding of the detailed scientific work being undertaken in their work package. They will monitor the progress of the WP to ensure that the work package fulfils the objectives listed as milestones and deliverables; alert the coordinator in case of delay or default in the performance of the WP; and deliver progress reports to the coordinator. The Coordination Team, which will be based at CISM will be a team of four people in order to develop all tasks related to the Consortium coordination as well as fulfil the commitment with the EDCTP binded by the Grant Agreement. The team will be composed by a: Coordinator (Dr Eusebio Macete), a Scientific Officer, Project Officer, a Communication Officer and a Grant Officer (financial)